CD45 Antibody Blocking peptide
CD45 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, L-CA, T200, CD45, PTPRC, CD45
UniProt
P08575
Field of Research
Immunology & Inflammation
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1935072 was selected from the C-term region of human CD45 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
More Discoveries
Explore Other Products
Browse additional items from our catalog
